| Long name: |
CACNA1F Primary Polyclonal Antibody |
| Also known as: |
CACNA1F PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
CACNA1F |
| Specificity: |
This is a highly specific antibody against CACNA1F |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Subcellular location: |
Extracellular |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CACNA1F |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
L-type Ca2+ currents initiate muscle contraction, L-type calcium channels may form macromolecular signaling complexes with G protein-coupled receptors, N-, P-, Q-, T-, and R- types, and can be regulated through second-messenger activated protein phosphorylation pathways, and gene transcription, and they are involved in a variety of Ca2+-dependent processes, endocrine secretion, hormone or neurotransmitter release and gene expression, including muscle contraction, thereby enhancing the selectivity of regulating specific targets, Ca2+ currents are characterized on the basis of their biophysical and pharmacologic properties and include L-, Voltage-dependent Ca2+ channels mediate Ca2+ entry into excitable cells in response to membrane depolarization |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
CAC1F_HUMAN, CACNAF, CACNAF1, COD 3, COD3, CORDX, CORDX 3, CORDX3, CSNB2A, CSNBX 2, CSNBX2, Calcium channel voltage dependent L type alpha 1F subunit, Calcium channel voltage dependent alpha 1F subunit, Cav1, Cav1, JM 8, JM8, JMC 8, JMC8, Voltage ated calcium channel subunit alpha Cav1, Voltage ependent L ype calcium channel subunit alpha F, 4, 4, 4alpha1, CACNA 1F |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
CACNA1F |
| Short name: |
CACNA1F Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
CACNA1F (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
1393 |
| Gene: |
CACNA1F |
More about : CACNA1F |
| Long gene name: |
calcium voltage-gated channel subunit alpha1 F |
| Synonyms gene: |
CSNB2 AIED |
| Synonyms gene name: |
Aland island eye disease (Forsius-Eriksson ocular albinism, L type, alpha 1F subunit , ocular albinism type 2) calcium channel, voltage-dependent |
| Synonyms: |
Cav1, 4 JM8 JMC8 CSNBX2 CORDX3 CSNB2A OA2 |
| Locus: |
Xp11, 23 |
| Discovery year: |
1997-04-21 |
| GenBank acession: |
AA019975 |
| Entrez gene record: |
778 |
| Pubmed identfication: |
9344658 9662400 16382099 12111638 17525176 |
| RefSeq identity: |
NM_005183 |
| Classification: |
Calcium voltage-gated channel subunits |
| Havana BLAST/BLAT: |
OTTHUMG00000022703 |
| Locus Specific Databases: |
Mutations of the L-type Calcium-Channel Gene Mental Retardation database |